chris

Comms | Biopharma. Ex-pat from the great state of New Jersey. Tweets are most certainly my own.

[Yashar Ali 🐘 @yashar]

Oh man, I had no idea Kenny Rogers sang “The Gambler” with Phish!

This was at Bonnaroo in 2012.

In interviews, Kenny said Phish came to his dressing room and asked if he would join them onstage for a song, and he said yes.

Kenny said Phish was one of those groups he had heard of but didn’t really know, and that it wasn’t until then that he realized how big they were.

Kenny had performed his own set earlier that afternoon in one of Bonnaroo’s large tents.

Later that night, he joined Phish on the main stage to sing in front of 70,000 people..

Kenny said the last time he had performed for a crowd that big was probably in the mid 80s.

So great.

[chris @ridscm]

@DeadsoundApp Epic Bill Payne work here too

[Reuters @Reuters]

Moderna CEO Stephan Bancel recalls he was at a Lebanese restaurant celebrating a friend’s birthday the moment he learned of a cancer vaccine's successful trial

[Matthew Herper @matthewherper]

"Stéphane used to ask me when he’d meet me in the corridor. … ‘So, is this thing going to work?’” Tal Zaks, Moderna's chief medical officer, remembered.

“And I used to say, ‘Stéphane, I honestly don’t know. All I know is that I feel like we’ve been put on earth to test this hypothesis.”

That's my favorite line from the Moderna story we published yesterday.

And, well, social media is a funny thing. Sometimes stories blow up here or on LinkedIn and nobody clicks.
Other times people here don't pay much attention, yet there are a ton of readers.

Which is to say a lot of people are reading this story, so maybe you should check it out. Yes, you'd need to subscribe.

https://t.co/M9Q8WDlgM5

[The Wall Street Journal @WSJ]

After its Covid success, Moderna endured years of falling vaccine sales, a plummeting stock price and attacks on its science. Now, its melanoma vaccine data notched a much-needed win for the company. https://t.co/W7IIy96F6z

[The Wall Street Journal @WSJ]

After years of layoffs, cash burn and political attacks on its core technology, Moderna’s melanoma vaccine data notched the biotech company a much-needed win. https://t.co/FgDir5DEdu

[chris @ridscm]

The road to new cures can be long and winding. Moderna shows sticking with it can pay off.

https://t.co/PB6TDD13D1

[Moderna @moderna_tx]

Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with completely resected Stage IIB-IV melanoma.
Read more:

[U.S. FDA @FDA]

FDA has approved the first mRNA-based seasonal influenza vaccine for adults 50 years and older. The vaccine is indicated for the prevention of influenza disease caused by influenza A subtypes and influenza B strains represented in the vaccine.

Approval includes:
➡️Traditional Approval for adults 50–64 years based on clinical efficacy
➡️Accelerated Approval for adults 65+ based on immune responses, with a required post-approval study to confirm clinical benefit

[The New York Times @nytimes]

Breaking News: The FDA approved the first mRNA flu vaccine, enabling a faster way to target particularly dangerous strains. https://t.co/1OaJCVLxvX

[chris @ridscm]

@DeadsoundApp He was the opening act that night for New Riders, with Bobby and Donna/Keith. Full Springsteen show is online and it’s awesome. https://t.co/UsjKv6TMgm

[ABC News @ABC]

Moderna has begun a Phase 1 clinical trial of an Ebola vaccine set to target the Bundibugyo strain, which is currently circulating in the eastern Democratic Republic of the Congo, the pharmaceutical company announced Tuesday. https://t.co/18lRhnIZHq

[chris @ridscm]

Always unflappable and one of the best in the business.

[The Daily Show @TheDailyShow]

.@KaitlanCollins on Trump's verbal attacks:

"It's really not about me, and I don't want it to be about my reaction. ... In those moments it's important to put the reminder back on the work, on the question, and on the non-answers that we get."

[Andrew Guenther @codebrewed]

I love how TSA rules are different at every airport and they look at you like you're a fucking idiot when you don't speak their regional dialect of security theater.

[Lulu Cheng Meservey @lulumeservey]

Palmer gets it:

If you're going to say something everyone agrees with, you might as well have said nothing at all.

You're not going to build a following of people who say, "I just love his right-down-the-middle, very hedged takes that everyone agrees with."

If some people love what you're saying and some people hate what you're saying, that's a lot better than having everybody lukewarm agree with you.

Don't waste time communicating about what everyone already agrees on. Focus on the things where you need to change their mind.

[Moderna @moderna_tx]

Happy Fourth of July! 🇺🇸

[chris @ridscm]

$mrna

[Peter Baker @peterbakernyt]

The average life expectancy of a new Russian recruit—from arrival at a training ground to death in a combat zone—lies somewhere between 10 days and three weeks. Once sent onto the battlefield, they survive an average of 20 to 35 minutes. @peterfrankopan https://t.co/W3UhBerdH0

[Tim Ryan @TimRyan]

This is a phenomenal piece by @Scaramucci these are the kind of reforms and new ideas we need. Not the same old bad solutions to tough problems. I appreciate the honesty here. @robertwolf32

[RNA Alliance @rnaalliance]

Today's unanimous VRBPAC vote is great news for the future of mRNA medicines and for patients who deserve better flu protection.

mRNA innovation deserves a fair shot, and today it got one.